AKR1B15 | Aldo-keto reductase family 1, member B15 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANXA13 | Annexin A13 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
B3GALT2 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
CA9 | Carbonic anhydrase IX | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CASR | Calcium-sensing receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CPA3 | Carboxypeptidase A3 (mast cell) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP4F11 | Cytochrome P450, family 4, subfamily F, polypeptide 11 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FGF5 | Fibroblast growth factor 5 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FNDC1 | Fibronectin type III domain containing 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FOSL1 | FOS-like antigen 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
FXYD2 | FXYD domain containing ion transport regulator 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GLP2R | Glucagon-like peptide 2 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
LCN2 | Lipocalin 2 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LGALS2 | Lectin, galactoside-binding, soluble, 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
LIF | Leukemia inhibitory factor | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MFAP2 | Microfibrillar-associated protein 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
ONECUT2 | One cut homeobox 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PLD1 | Phospholipase D1, phosphatidylcholine-specific | Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
SNAI1 | Snail family zinc finger 1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
SYT13 | Synaptotagmin XIII | Predicted intracellular proteins
| | | | | Tissue enhanced |
TNFAIP6 | Tumor necrosis factor, alpha-induced protein 6 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TNFSF18 | Tumor necrosis factor (ligand) superfamily, member 18 | Predicted membrane proteins
| | | | | Tissue enhanced |
TPSAB1 | Tryptase alpha/beta 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TPSB2 | Tryptase beta 2 (gene/pseudogene) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |